Priority Date: 05.09.11 (GB 20110015280)

ANTI-CD40 ANTIBODIES, USES AND METHODS

  • Application ID: EP12761786
  • Status: The patent has been granted

Attorney

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Potter Clarkson LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 226 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 05.09.2011 - Priority Date (GB 20110015280)
  • 14.03.2013 - Publication A1 (WO2013034904)
  • 16.07.2014 - Publication A1 (EP2753646)
  • 22.11.2017 - Publication B1 (EP2753646)

IPC Classification